Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 2609-46-3
Drug Levels and Effects
Summary of Use during Lactation
Minimal information on the use of amiloride during breastfeeding found a slightly elevated serum potassium and low serum and urinary magnesium levels in one breastfed infant, suggested a systemic effect. An alternate drug may be preferred.
Drug Levels
Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Intense diuresis can suppress lactation;[1,2] however, it is unlikely that amiloride alone is sufficiently potent to cause this effect.
A woman with Gitelman syndrome was prescribed amiloride 5 mg daily. She became pregnant and delivered a healthy infant. Amiloride was initially discontinued during breastfeeding, but restarted at 6 weeks postpartum. While on amiloride, the baby’s laboratory values showed a serum potassium of 5.8 mmol/L and a serum magnesium of 2.3 mg/dL. Spot urine concentrations of magnesium were < 1.4 mg/dL, urine creatinine was 5 mg/dL, and urine potassium was 5 mmol/L. Amiloride was stopped for one week and laboratory tests were repeated. Serum potassium was 4.8 mmol/L, magnesium was 2.2 mg/dL and a urine magnesium concentration was 1.7 mg/dL. Urine creatinine was 8 mg/dL, and urine potassium was 6 mmol/L.[3]
Alternate Drugs to Consider
References
- 1.
- Healy M. Suppressing lactation with oral diuretics. Lancet 1961;277:1353-4. doi:10.1016/S0140-6736(61)90289-6 [CrossRef]
- 2.
- Cominos DC, Van Der Walt A, Van Rooyen AJ. Suppression of postpartum lactation with furosemide. S Afr Med J 1976;50:251-2. [PubMed: 3858]
- 3.
- Ibrahim A, Rodan AR, Westenfelder C, et al. Gitelman syndrome patient managed with amiloride during pregnancy and lactation. BMC Nephrol 2024;25:403. [PMC free article: PMC11550528] [PubMed: 39521975]
Substance Identification
Substance Name
Amiloride
CAS Registry Number
2609-46-3
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PMCPubMed Central citations
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Iodine.[Drugs and Lactation Database (...]Review Iodine.. Drugs and Lactation Database (LactMed®). 2006
- Review Melatonin.[Drugs and Lactation Database (...]Review Melatonin.. Drugs and Lactation Database (LactMed®). 2006
- Review Methadone.[Drugs and Lactation Database (...]Review Methadone.. Drugs and Lactation Database (LactMed®). 2006
- Review Cannabis.[Drugs and Lactation Database (...]Review Cannabis.. Drugs and Lactation Database (LactMed®). 2006
- Review Alcohol.[Drugs and Lactation Database (...]Review Alcohol.. Drugs and Lactation Database (LactMed®). 2006
- Amiloride - Drugs and Lactation Database (LactMed®)Amiloride - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...